Global IVD Market 2014-2018

2014-06-30
Price :
Published : Jun-2014
No. of Pages : 91

IVDs are widely used to diagnose, monitor, and assess medical conditions, diseases, or infections usually in a controlled environment. IVD tests provide outcomes for earlier and more targeted treatment. These tests are minimally invasive, help reduce hospital stay, and provide accurate results. This kind of diagnostics provides early detection of diseases and thereby helps better control and curb the burden of diseases across the world.

TechNavio’s analysts forecast the Global IVD market will grow at a CAGR of 6.86 percent over the period 2013-2018.

Covered in this Report

The Global IVD market can be categorized on the basis of type of test into the following segments: POC, Core Laboratory, Molecular, Hematology, Coagulation, Microbiology, Blood Banking, and Histology/Cytology.

TechNavio’s report, the Global IVD Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global IVD market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Abbott Laboratories
  • Johnson & Johnson
  • Roche Diagnostics Inc.
  • Siemens Healthcare

Other Prominent Vendors

  • 23andMe
  • A. Menarini Diagnostics
  • Affymetrix
  • Agilent Technologies
  • Alere
  • ARKRAY
  • Axis-Shield
  • Bio-Rad Laboratories
  • Bruker BioSciences
  • Celera Diagnostics
  • Cepheid
  • China Medical Technologies
  • Dako
  • DiaSorin
  • Eiken Chemical
  • ELITech
  • Fujirebio Diagnostics
  • GE Healthcare
  • Grifols
  • Horiba
  • Illumina
  • Instrumentation Laboratory
  • IRIS International
  • Luminex
  • Magellan Biosciences
  • Nanosphere
  • Nova Biomedical
  • Nova Century Scientific
  • Novartis
  • PerkinElmer
  • Phadia
  • QIAGEN
  • Quidel
  • Randox Laboratories
  • Sequenom
  • Shenzhen Mindray Bio-Medical Electronics
  • Siemens Healthcare
  • Spartan Bioscience
  • Sysmex
  • Thermo Fisher Scientific
  • Tosoh
  • Transasia Bio-Medicals
  • Trinity Biotech
  • Ventana Medical Systems
  • Veridex
  • Wako Pure Chemical Industries
  • Werfen Life Group

Key Market Driver

  • Rapid Increase in Aging Population
  • For a full, detailed list, view our report.

Key Market Challenge

  • Issues with Regulatory Framework
  • For a full, detailed list, view our report.

Key Market Trend

  • Increased Adoption of POC Diagnostic Tests
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Diagnostics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Transplant Diagnostics Market 2016-2020

Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients. The analysts forecast global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global......
$2500

IVD Market in Europe 2016-2020

IVD tests help diagnose, monitor, and assess medical conditions, diseases, and infections in a controlled environment. These tests help in early diagnosis of diseases by enhancing control on test procedures and provide accurate results, leading to quality treatment and shorter hospital stays. They are also minimally invasive and help in lowering treatment costs. Manufacturers develop reagents, analytical instruments such as automated analyzers, and accessory products including software to measure the quality and parameters of samples. The analysts forecast IVD market in Europe to grow at a CAGR of 4.78% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the IVD market in Europe for 2016-2020. To calculate the mar......
$2500

Global Rapid Diagnostics Market 2016-2020

Rapid diagnostic tests are diagnostic assays designed for low-resource settings that provide faster results. These can be carried out either at a patient's bedside or in a clinical setting. These devices are simple to operate and read, have a low cost, and are specific, sensitive, and stable at extreme temperatures. They also provide quick results. Rapid diagnostics is the fastest-growing segment in in vitro diagnostics (IVD). Rapid diagnostic tests include agglutination, lateral flow, flow through, solid phase, and nucleic-acid amplification tests. Diagnostic devices are used to detect and measure blood glucose and coagulation levels, cardiac biomarkers, infectious diseases, hemoglobin concentration, five-part differential blood count, and pregnancy and fertility status. These tests can b......
$2500

Global Molecular Diagnostics Market 2016-2020

The traditional trial and error techniques that were used in the field of medicine are now being replaced by accurate, safe, marker-assisted, molecular-guided treatments. Molecular diagnostics is one such technique. This is a technique that involves measurement and analysis of DNA and RNA at the molecular level to detect changes in biochemical pathways. The aim of performing these tests is to determine the location of a disease and its activity. Wide scope of application, specificity, and quick turnaround time are factors that are contributing to its importance in the IVD market. The analysts forecast global molecular diagnostics market to grow at a CAGR of 10.38% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects o......
$2500

Global Tissue Diagnostics Market 2016-2020

Tissue diagnostics involves the diagnosis of diseases or analysis of the biological causes of the disease by extracting and analyzing a specific tissue. It has a broad range of applications in clinical research, clinical diagnostics, and cell biology. It is considered one of the most accurate techniques for the diagnosis of inflammatory conditions. Medical specialists particularly use tissue diagnostics in the area of molecular biology for cancer screening, therapy selection, diagnosis, and relapse monitoring. It helps in the screening and diagnosis of lymphoma, melanoma, leukemia, and breast, ovarian, cervical, head and neck, pancreatic, non-small cell lung, colorectal, brain, prostate, lung, and endometrial cancers. Pathologists use different technologies such as in situ hybridization (I......
$2500

Solid Tumor Testing Market in the US 2016-2020

Solid tumor testing or screening is done for the early detection of cancer, enabling effective treatment measures to avoid the spread of cancerous cells throughout the body. The testing procedure involves testing of samples such as urine, blood, and other bodily substances. Further, cancer testing also involves conducting genetic tests to analyze certain gene mutations that are linked to certain cancer types. Biopsy, colonoscopy, Papanicolaou (Pap) test, and fecal occult blood tests are some of the tests that are performed for cancer screening. The analysts forecast solid tumor testing market in the US to grow at a CAGR of 11.1% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the solid tumor testing market in t......
$2500

Global E. Coli Testing Market 2016-2020

Escherichia coli (E. coli) are the leading cause of diarrheal diseases worldwide, especially among children. E. coli infection primarily occurs through food or drinking water contaminated with animal or human feces. The bacteria produce Shiga toxin that causes gastrointestinal (GI) infections with symptoms including bloody diarrhea and vomiting. Though the infections are usually cured in a few days, at times, they may lead to hemolytic uremic syndrome. This syndrome, if untreated, can result in kidney failure. E. coli tests are used to diagnose GI infections using stool samples. These tests can be performed using molecular diagnostic kits and immunoassays. The analysts forecast global E. coli testing market to grow at a CAGR of 5.81% during the period 2016-2020. Covered in this repor......
$2000

POCT Market in Europe 2015-2019

POCT is the fastest growing segment of laboratory diagnostics in Europe. It is performed using electronic and non-electronic devices that range from reaction strips to bulky devices. These devices replace a series of laboratory experiments and reduce the turnaround time. POCT diagnostic devices can be categorized into hand-held and near-bedside monitoring devices. The hand-held POCT devices are small, offering mobility while the near-bedside POCT devices are larger and complex. For both the devices, quality control and calibration functionality are checked before performing the tests. The analysts forecast POCT market in Europe to grow at a CAGR of 4.07% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the point......
$2500

Infectious Disease Testing Market in the US 2015-2019

Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of he......
$2500

Vitamin D Testing Market in the US 2015-2019

Market outlook of the vitamin D testing market in the US The market research analyst has estimated this market to show steady growth during the forecast period. The prospect for growth in this market is dependent on factors like the high incidence of vitamin D deficiency among the populace in this region, which results in its slow but moderate CAGR of around 4% by 2019. The prevention of various acute and chronic diseases is the key driver for the growth of this market. Vitamin D deficiency can lead to various chronic diseases like rickets and osteoporosis, and can also result in cardiovascular diseases, cancer, asthma in infants, cognitive disorders, and autoimmune diseases. The incidence of these diseases can be reduced by frequently testing the vitamin D levels, which in turn woul......
$2500